Immunocore Holdings plc (IMCR) Financials

IMCR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 597.0 million 228.2 million
2023-09-30 464.1 million 172.6 million
2023-06-30 440.4 million 163.1 million
2023-03-31 430.5 million 156.4 million

IMCR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -9.1 million 12.1 million
2023-09-30 3.4 million 6.7 million
2023-06-30 -3.2 million 7.0 million
2023-03-31 6.3 million 6.7 million

IMCR Net Income

No data available :(

IMCR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 442.6 million - 36.0 million
2023-09-30 364.0 million - 30.9 million
2023-06-30 342.3 million - 29.1 million
2023-03-31 337.5 million - 29.5 million

IMCR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 48.9 million
2023-09-30 54.2 million
2023-06-30 48.7 million
2023-03-31 48.2 million

IMCR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 471000 74.7 million 47.0 million 17.2 million
2023-09-30 1.7 million 31.7 million 11.0 million -
2023-06-30 768000 28.8 million 36.0 million -
2023-03-31 2.5 million 28.4 million 33.3 million -

IMCR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 105.6 million -247000
2023-09-30 51.5 million 220000
2023-06-30 47.8 million 886000
2023-03-31 44.5 million 178000

IMCR

Price: $58.46

52 week price:
42.21
76.98

Earnings Per Share: -1.43 USD

P/E Ratio: -52.59

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 522338

Market Capitalization: 3.2 billion

Links: